Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
125.08
-0.32 (-0.26%)
At close: Dec 5, 2025, 4:00 PM EST
125.26
+0.18 (0.14%)
After-hours: Dec 5, 2025, 7:55 PM EST
Abbott Laboratories Stock Forecast
Stock Price Forecast
The 18 analysts with 12-month price forecasts for Abbott Laboratories stock have an average target of 146.61, with a low estimate of 135 and a high estimate of 162. The average target predicts an increase of 17.21% from the current stock price of 125.08.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Abbott Laboratories stock from 18 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 9 | 9 | 9 | 9 | 9 |
| Buy | 8 | 8 | 8 | 8 | 7 | 7 |
| Hold | 4 | 3 | 3 | 3 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19 | 20 | 20 | 20 | 18 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Reiterates $145 | Strong Buy | Reiterates | $145 | +15.93% | Nov 20, 2025 |
| Barclays | Barclays | Buy Maintains $159 → $162 | Buy | Maintains | $159 → $162 | +29.52% | Oct 17, 2025 |
| Raymond James | Raymond James | Buy Maintains $141 → $146 | Buy | Maintains | $141 → $146 | +16.73% | Oct 16, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $144 → $142 | Buy | Maintains | $144 → $142 | +13.53% | Oct 16, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $147 | Buy | Reiterates | $147 | +17.52% | Oct 16, 2025 |
Financial Forecast
Revenue This Year
45.12B
from 41.95B
Increased by 7.56%
Revenue Next Year
48.71B
from 45.12B
Increased by 7.96%
EPS This Year
5.20
from 7.64
Decreased by -31.88%
EPS Next Year
5.73
from 5.20
Increased by 10.15%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 47.1B | 53.0B | ||||
| Avg | 45.1B | 48.7B | ||||
| Low | 43.7B | 46.2B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 12.2% | 17.4% | ||||
| Avg | 7.6% | 8.0% | ||||
| Low | 4.1% | 2.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 5.44 | 6.14 | ||||
| Avg | 5.20 | 5.73 | ||||
| Low | 5.04 | 5.40 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -28.8% | 18.0% | ||||
| Avg | -31.9% | 10.2% | ||||
| Low | -34.1% | 3.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.